Director at Aethlon (NASDAQ: AEMD) forfeits shares to cover taxes

Rhea-AI Filing Summary

Aethlon Medical director Edward G. Broenniman reported a routine tax-withholding disposition related to restricted stock units. He forfeited 89 shares of common stock, valued at $2.19 per share, to cover taxes upon conversion of 357 vested RSUs. After this transaction, he directly holds 1,915 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BROENNIMAN EDWARD G

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	89	$2.19	$194.91

Holdings After Transaction: Common Stock — 1,915 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares forfeited for taxes: 89 shares Forfeiture price per share: $2.19 per share Shares held after transaction: 1,915 shares +1 more

4 metrics

Shares forfeited for taxes 89 shares Tax-withholding disposition on vested RSUs

Forfeiture price per share $2.19 per share Market price used for tax withholding

Shares held after transaction 1,915 shares Director’s direct holdings following Form 4 event

RSUs converted 357 units Vested restricted stock units converted into common stock

Key Terms

restricted stock units, tax withholdings, Form 4

3 terms

restricted stock units financial

"conversion of an aggregate 357 vested and outstanding restricted stock units into shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholdings financial

"shares of common stock to cover tax withholdings, using the market price"

Form 4 regulatory

"grant reported in Table I of the Form 4 filed by the Reporting Person"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROENNIMAN EDWARD G

(Last) (First) (Middle)

11555 SORRENTO VALLEY ROAD, SUITE 203

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		F		89(1)	D	$2.19	1,915	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person forfeited 89 shares of common stock upon conversion of an aggregate 357 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.

	/s/ Edward G. Broenniman by: James B. Frakes, Attorney-in-fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Aethlon Medical (AEMD) director Edward Broenniman report on this Form 4?

He reported a tax-related share forfeiture, not an open-market trade. Broenniman forfeited 89 Aethlon Medical common shares to cover taxes when 357 vested restricted stock units converted into shares, a routine compensation-related event.

How many Aethlon Medical (AEMD) shares did the director forfeit for taxes?

Edward Broenniman forfeited 89 shares of common stock. The shares were surrendered to cover tax withholdings tied to the conversion of 357 vested restricted stock units, using the market price of Aethlon Medical stock at the time of forfeiture.

What price per share was used for the Aethlon (AEMD) tax-withholding disposition?

The Form 4 lists a price of $2.19 per share for the 89 forfeited shares. This reflects the market price of Aethlon Medical’s common stock at the time the shares were surrendered to satisfy tax obligations on vested restricted stock units.

How many Aethlon Medical (AEMD) shares does the director hold after this Form 4 transaction?

Following the tax-withholding disposition, Edward Broenniman holds 1,915 Aethlon Medical shares directly. This figure reflects his direct ownership after forfeiting 89 shares to cover taxes associated with the conversion of previously granted restricted stock units.

Was this Aethlon Medical (AEMD) Form 4 an open-market sale by the director?

No, the filing shows a tax-withholding disposition, not an open-market sale. Shares were forfeited to satisfy tax obligations when 357 vested restricted stock units converted into common stock, a standard mechanism for handling equity award taxes.

What equity award activity triggered the Aethlon (AEMD) tax share forfeiture?

The forfeiture stemmed from 357 vested restricted stock units converting into common shares. To cover the resulting tax withholdings, 89 of those shares were surrendered at the market price, while the remaining shares from the award were retained.